Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers

This article was originally published in The Tan Sheet

Executive Summary

Nanotechnology experts, speaking at a meeting organized for FDA's Internal Nanotechnology Task Force, debated whether gaps in FDA's regulation of the technology actually represent problems for the industry and consumers

Related Content

Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements
FDA Eyes Nanotech Standards Process With More Unknown Than Known
Nanotech Report’s Recommendations Unsettling To Supplement Industry
Commercialization Phase Brings New Challenges To Nanotech Industry
EPA Would Regulate Nano Materials Under Research Project’s Proposal
EC Committee Proposes New Nanomaterials Risk Assessment Procedure
Multilayer Emulsions Deliver Goods For Nano-Engineered Food – Researchers
2008 Budget Should Cover Research On Nanotech Risk – Congressmen
Nanotech Boom Presents Challenges For Both Industry, Regulators
FDA Nanotechnology Oversight Limited By Budget Constraints – Report





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts